Oncolytics Biotech (ONCY)

Oncolytics Biotech (ONCY) Financial Statements


Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently ―. The company's EPS TTM is $-0.374; its P/E ratio is -3.87; Oncolytics Biotech is scheduled to report earnings on March 8, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----C$ 0.00
Gross Profit-----
EBITC$ -9.92MC$ -7.39MC$ -6.44M-C$ -6.06M
EBITDAC$ -9.81MC$ -7.30MC$ -6.34M-C$ -5.96M
Net Income Common StockholdersC$ -9.93MC$ -7.44MC$ -6.44MC$ -8.55MC$ -4.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 39.98MC$ 24.35MC$ 29.67MC$ 32.14MC$ 32.36M
Total AssetsC$ 46.09MC$ 31.97MC$ 35.33MC$ 37.33MC$ 38.96M
Total DebtC$ 514.00KC$ 479.00KC$ 567.00KC$ 373.00KC$ 460.78K
Net DebtC$ -39.47MC$ -23.87MC$ -29.10MC$ -31.77MC$ -31.90M
Total LiabilitiesC$ 17.07MC$ 9.73MC$ 9.58MC$ 10.83MC$ 10.56M
Stockholders EquityC$ 29.02MC$ 22.24MC$ 25.75MC$ 26.50MC$ 28.40M
Cash Flow-
Free Cash FlowC$ -6.03MC$ -8.46MC$ -7.83M-C$ -4.26M
Operating Cash FlowC$ -6.03MC$ -8.46MC$ -7.83MC$ -5.94MC$ -4.25M
Investing Cash FlowC$ 6.77MC$ 6.79MC$ 6.67MC$ -20.35MC$ -8.57K
Financing Cash FlowC$ 21.29MC$ 3.69MC$ 5.27MC$ 5.87MC$ 1.16M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Oncolytics Biotech Debt to Assets

Oncolytics Biotech Cash Flow

Oncolytics Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis